50 Participants NeededMy employer runs this trial

Sodium Intake for Atopic Dermatitis and Psoriasis

(SIS-ISD Trial)

Recruiting at 1 trial location
AH
KA
Overseen ByKatrina Abuabara, MD
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores how altering salt intake affects skin conditions such as atopic dermatitis and psoriasis. Researchers aim to determine if a link exists between sodium levels in the skin and the severity of these conditions. Participants will alternate between consuming sodium chloride tablets (salt tablets) and placebo pills while adhering to a low-salt diet. This trial suits adults with atopic dermatitis or psoriasis who can undergo an MRI and are not affected by specific medical conditions or medications. As a Phase 4 trial, the treatment is already FDA-approved and proven effective, aiming to understand how it benefits more patients.

Do I have to stop taking my current medications for the trial?

You may need to stop certain medications, especially those that affect sodium excretion or if you've taken antibiotics or immunomodulatory drugs in the last month. However, some topical treatments and stable doses of eczema medications are allowed. There is a 2-week period without taking sodium tablets or placebo, known as a washout period.

What is the safety track record for these treatments?

Research has shown that excessive salt intake might affect skin problems like eczema and psoriasis. This study focuses on salt tablets. Some research suggests that high salt levels can increase certain immune cells, possibly worsening skin issues. However, these studies did not involve human participants.

Regarding safety, salt is a common part of the diet, suggesting that this treatment is likely safe when used carefully. However, excessive salt can cause issues like high blood pressure or swelling in some individuals.

Overall, the treatment appears safe, but it is crucial to follow dosage instructions and consult a doctor if any concerns arise.12345

Why are researchers enthusiastic about this study treatment?

Most treatments for atopic dermatitis and psoriasis, like topical corticosteroids and biologics, work by reducing inflammation or modifying the immune system. But sodium chloride tablets offer a unique approach by potentially influencing skin conditions through dietary sodium regulation. Researchers are excited because this treatment could represent a simple, oral addition to current therapies, possibly offering relief with fewer side effects. This novel method of managing skin inflammation through sodium intake is what makes it stand out from traditional options.

What evidence suggests that this trial's treatments could be effective for atopic dermatitis and psoriasis?

Research has shown that people with atopic dermatitis, a condition causing itchy and inflamed skin, have much higher sodium levels in their skin compared to those without it. One study found sodium levels in the skin were 30 times higher in individuals with this condition. Another study suggested that reducing sodium intake might lower the chances of flare-ups in atopic dermatitis. For psoriasis, which causes red, scaly skin patches, higher sodium consumption was linked to an 18% increased risk of developing the condition. Lab studies indicate that sodium might activate certain immune cells, worsening these skin conditions. Therefore, managing sodium intake could be important in treating atopic dermatitis and psoriasis. This trial will compare the effects of sodium chloride tablets and placebo tablets on these conditions, with participants receiving both treatments in different sequences.14678

Who Is on the Research Team?

KA

Katrina Abuabara, MD

Principal Investigator

University of California, San Francisco

Are You a Good Fit for This Trial?

This trial is for adults (18+) with atopic dermatitis or psoriasis who can undergo MRI scans. Participants must have stable treatment for their skin condition and cannot join if they have recent heart events, kidney or liver problems, certain implants, take medicines affecting sodium levels, or recently used antibiotics or immune drugs.

Inclusion Criteria

I only use topical medications on my head, neck, hands, or feet.
Willing and able to undergo non-contrast MRI
I am at least 18 years old.
See 2 more

Exclusion Criteria

I am taking medicines that affect how my body gets rid of sodium.
I have taken antibiotics or immune system medications in the past month.
I cannot safely take sodium tablets.
See 3 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2 weeks
1 visit (in-person)

Wash-in

Participants follow a low-salt diet alone to acclimate before starting the intervention

1 week
1 visit (in-person)

Treatment

Participants receive sodium chloride tablets or placebo for 5 weeks, followed by a 2-week washout, then switch to the alternate treatment for another 5 weeks

12 weeks
4 visits (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Placebo Tablets
  • Sodium chloride tablets

Trial Overview

The study tests how taking salt tablets versus placebo affects skin sodium levels and the severity of eczema and psoriasis. All participants follow a low-salt diet during the 13-week trial and switch between salt tablets and placebo after a washout period.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Group I: Sodium tablets firstExperimental Treatment2 Interventions
Group II: Placebo tablets firstExperimental Treatment2 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of California, San Francisco

Lead Sponsor

Trials
2,636
Recruited
19,080,000+

LEO Foundation

Collaborator

Trials
1
Recruited
60+

Citations

The Impact of Salt Intake on Sodium in the Skin ...

The goal of this clinical trial is to demonstrate the feasibility of a trial that examines the impact of changes in dietary sodium intake on ...

2.

pubmed.ncbi.nlm.nih.gov

pubmed.ncbi.nlm.nih.gov/38837130/

Sodium Intake and Atopic Dermatitis

These findings suggest that restriction of dietary sodium intake may be a cost-effective and low-risk intervention for AD.

Sodium Intake and Atopic Dermatitis

One small study found that the amount of lesional skin sodium was 30 times greater among patients with AD compared with healthy control ...

Sodium intake: An emerging dietary target in psoriasis

The results showed that each 1 g increase in estimated 24-h urinary sodium was associated with an 18% higher risk of psoriasis. These findings ...

Study Finds Association Between Sodium Intake and Risk ...

Reducing sodium intake is associated with decreased risk of atopic dermatitis (AD) and flares.

Salt and Skin: Could Sodium Be Fueling Psoriasis and Atopic ...

We've had several in vitro studies now showing that high levels of sodium could actually increase Th2 and Th17 cells, which are relevant for ...

Salt Intake on Sodium in the Skin and Inflammatory Skin ...

The goal of this clinical trial is to demonstrate the feasibility of a trial that examines the impact of changes in dietary sodium intake on skin sodium ...

The Impact of Salt Intake on Sodium in the Skin ...

Participants will be randomized to receive placebo tablets for weeks 2-6, no tablets for a washout period during weeks 7-8, then sodium tablets for weeks 9-13.